Log in

Lombard Medical Stock Price, News & Analysis (OTCMKTS:EVARF)

0.00 (0.00 %)
(As of 10/20/2019 04:00 PM ET)
Today's Range
Now: $0.00
50-Day Range N/A
52-Week Range
Now: $0.00
Average Volume1,584 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Lombard Medical, Inc, a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Previous SymbolNASDAQ:EVAR



Sales & Book Value

Annual Sales$12.17 million



Next Earnings DateN/A
OptionableNot Optionable

Receive EVARF News and Ratings via Email

Sign-up to receive the latest news and ratings for EVARF and its competitors with MarketBeat's FREE daily newsletter.

Lombard Medical (OTCMKTS:EVARF) Frequently Asked Questions

What is Lombard Medical's stock symbol?

Lombard Medical trades on the OTCMKTS under the ticker symbol "EVARF."

How were Lombard Medical's earnings last quarter?

Lombard Medical Inc (OTCMKTS:EVARF) posted its quarterly earnings data on Thursday, October, 27th. The medical equipment provider reported ($0.37) EPS for the quarter, missing the Zacks' consensus estimate of ($0.27) by $0.11. The medical equipment provider had revenue of $3.04 million for the quarter, compared to the consensus estimate of $3.16 million. View Lombard Medical's Earnings History.

Has Lombard Medical been receiving favorable news coverage?

News stories about EVARF stock have been trending somewhat positive on Sunday, according to InfoTrie. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Lombard Medical earned a daily sentiment score of 0.8 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Lombard Medical.

Who are some of Lombard Medical's key competitors?

What other stocks do shareholders of Lombard Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lombard Medical investors own include Celldex Therapeutics (CLDX), Synergy Pharmaceuticals (SGYP), Cytori Therapeutics (CYTX), Gilead Sciences (GILD), NewLink Genetics (NLNK), NVIDIA (NVDA), Visa (V), SLS International (SLS), Adobe (ADBE) and Align Technology (ALGN).

Who are Lombard Medical's key executives?

Lombard Medical's management team includes the folowing people:
  • Mr. Kurt B. Lemvigh, Chief Exec. Officer (Age 51)
  • Dr. Peter Phillips, Chief Technology Officer (Age 60)
  • Andrew Debbage, VP of Operations
  • Mr. Jonathan Hornsby, VP of Sales & Marketing
  • Ms. Kate Forster, VP of HR

How do I buy shares of Lombard Medical?

Shares of EVARF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Lombard Medical's stock price today?

One share of EVARF stock can currently be purchased for approximately $0.00.

What is Lombard Medical's official website?

The official website for Lombard Medical is http://www.lombardmedical.com/.

How can I contact Lombard Medical?

Lombard Medical's mailing address is 4 TRIDENT PARK BASIL HILL ROAD, DIDCOT X0, OX11 7HJ. The medical equipment provider can be reached via phone at 44-0-12-3575-0800.

MarketBeat Community Rating for Lombard Medical (OTCMKTS EVARF)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  135 (Vote Outperform)
Underperform Votes:  104 (Vote Underperform)
Total Votes:  239
MarketBeat's community ratings are surveys of what our community members think about Lombard Medical and other stocks. Vote "Outperform" if you believe EVARF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVARF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Featured Article: G-20

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel